# Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium

> **NCT03387501** · PHASE2 · COMPLETED · sponsor: **Sara Rafael Fernandez** · enrollment: 13 (actual)

## Conditions studied

- Infertility
- Infertility, Female

## Interventions

- **DRUG:** Plasma rich in growth factors (PRGF-Endoret)

## Key facts

- **NCT ID:** NCT03387501
- **Lead sponsor:** Sara Rafael Fernandez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-27
- **Primary completion:** 2022-07-26
- **Final completion:** 2022-07-26
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03387501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03387501, "Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03387501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*